Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€54.29

€54.29

2.550%
1.35
2.550%
€69.69
 
23.08.24 / Tradegate WKN: A2ALP4 / Symbol: TWLO / Name: Twilio / Stock / Large Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction

sharewise BeanCounterBot

The analysis provided is generated by an artificial intelligence system and is provided for informational purposes only. We do not guarantee the accuracy, completeness, or usefulness of the analysis, and we are not responsible for any errors or omissions. Use of the analysis is at your own risk.
The full analysis of the stock Twilio Inc is only available for our menbers.
Not a member yet? Sign up for free!

Financial data and news for Twilio

sharewise wants to provide you with the best news and tools for Twilio, so we directly link to the best financial data sources.

News

1 Incredibly Cheap Stock Down 21% to Buy Before It Jumps 95%: https://g.foolcdn.com/editorial/images/787713/person-holding-a-smartphone-with-a-stock-chart-on-screen.jpg
1 Incredibly Cheap Stock Down 21% to Buy Before It Jumps 95%

Twilio (NYSE: TWLO) investors have had a forgettable year so far. Shares of the cloud communications specialist lost 21% of their value in 2024, but the good part is that the recent stock price

Better Tech Stock: Twilio vs. Unity Software: https://g.foolcdn.com/editorial/images/786802/woman-cloud-tablet.jpg
Better Tech Stock: Twilio vs. Unity Software

Twilio (NYSE: TWLO) and Unity (NYSE: U) both hit their all-time highs during the buying frenzy in growth and meme stocks in 2021. Twilio's stock surged to $443.49 that February, representing a

Twilio (TWLO) Q2 2024 Earnings Call Transcript: https://g.foolcdn.com/editorial/images/1/featured-transcript-logo-template-2023-01-12.jpg
Twilio (TWLO) Q2 2024 Earnings Call Transcript

Image source: The Motley Fool.

Twilio (NYSE: TWLO)Q2 2024 Earnings CallAug 01, 2024, 5:00 p.m. ET

Operator

Continue reading

Source Fool.com

1 Incredibly Cheap Artificial Intelligence (AI) Stock to Buy Before It Skyrockets: https://g.foolcdn.com/editorial/images/783784/ai-written-on-cloud.jpg
1 Incredibly Cheap Artificial Intelligence (AI) Stock to Buy Before It Skyrockets

The proliferation of artificial intelligence (AI) has given a big boost to technology stocks in the past year, which is evident from the 30% gains clocked by the Nasdaq-100 Technology Sector index

Can Twilio Come Back in the Second Half of 2024?: https://g.foolcdn.com/editorial/images/783681/using-phone-while-on-the-go.jpg
Can Twilio Come Back in the Second Half of 2024?

Like many growth tech stocks, Twilio (NYSE: TWLO) benefited from a fantastic run in 2021 only to hit a wall in the 2022 bear market. Unfortunately, the communications platform-as-a-service (CPaaS)

This Incredibly Cheap Tech Stock Is Down 20% and Could Get a Boost Thanks to Artificial Intelligence (AI) -- But Should You Buy It?: https://g.foolcdn.com/editorial/images/778238/abstract-human-skull-representing-ai.jpg
This Incredibly Cheap Tech Stock Is Down 20% and Could Get a Boost Thanks to Artificial Intelligence (AI) -- But Should You Buy It?

This has been a terrible year for Twilio (NYSE: TWLO) investors so far, as shares of the company have fallen 20%. The cloud stock's negative returns are in stark contrast to those of the broader

Twilio (TWLO) Q1 2024 Earnings Call Transcript: https://g.foolcdn.com/editorial/images/1/featured-transcript-logo-template-2023-01-12.jpg
Twilio (TWLO) Q1 2024 Earnings Call Transcript

Image source: The Motley Fool.

Twilio (NYSE: TWLO)Q1 2024 Earnings CallMay 07, 2024, 5:00 p.m. ET

Operator

Continue reading

Source Fool.com

Could Twilio Stock Help You Become a Millionaire?: https://g.foolcdn.com/editorial/images/773348/cloud-smartphone-user.jpg
Could Twilio Stock Help You Become a Millionaire?

Twilio (NYSE: TWLO) likely minted a lot of millionaires in its first five years as a publicly traded company. The cloud-based communications software provider went public at $15 in June 2016, and it

Cathie Wood Is Selling These 2 Artificial Intelligence (AI) Stocks. Should You?: https://g.foolcdn.com/editorial/images/769687/young-woman-looking-at-laptop.jpg
Cathie Wood Is Selling These 2 Artificial Intelligence (AI) Stocks. Should You?

Out with the old. In with the new. Some investors might think that's Cathie Wood's strategy these days. And they'd have a point.

Wood's Ark Invest exchange-traded funds (ETFs) have been trimming

Have $1,000? These 2 Stocks Could Be Bargain Buys for 2024 and Beyond: https://g.foolcdn.com/editorial/images/768040/people-gathered-around-a-white-board-with-a-chart.jpg
Have $1,000? These 2 Stocks Could Be Bargain Buys for 2024 and Beyond

The stock market has gotten off to a solid start in 2024 with the S&P 500 index already up by close to 8% and setting new highs, and the good part is that the market could keep rising thanks to a

Twilio Moves Up Profitability Goal as Growth Era Comes to an End: https://g.foolcdn.com/editorial/images/768144/profits-ahead-yield-sign.jpg
Twilio Moves Up Profitability Goal as Growth Era Comes to an End

Twilio (NYSE: TWLO), once a growth-at-any-cost Wall Street darling, is remaking itself as a company focused on the bottom line. The communications software provider originally laid out a plan to

6 reasons to buy Teva Pharmaceuticals stock sooner than later: https://www.marketbeat.com/logos/articles/med_20240225160005_chartm-teva.jpg
6 reasons to buy Teva Pharmaceuticals stock sooner than later

Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) is a global pharmaceutical company in the medical sector specializing in generic and specialty medications. The company has been suffering under